@inproceedings{inproceedings, title  = {{In vivo priming with rhG-CSF increases the expression of CD33 in acute myeloid leukemia blast cells and possibly enhances the cytotoxic effect of Gemtuzumab-Ozamicin: Results of a pilot study.}},

 url = {{}},

 year = {{2003}},

 month = {{11}},

 author = {{Leone G and Rutella S and Scardocci A and Voso MT and Pagano L}},

 volume = {{102}},

 journal = {{BLOOD}},

 issue = {{11}},

 pages = {{256B-256B}},

 note = {{Accessed on 2026/02/25}}}